Mortality in patients with Klinefelter syndrome in Britain: a cohort study
Mortality in patients with Klinefelter syndrome in Britain: a cohort study
Context: Klinefelter syndrome is characterized by hypogonadism and infertility, consequent on the presence of extra X chromosome(s). There is limited information about long-term mortality in this syndrome because there have been no large cohort studies.
Objective: Our objective was to investigate mortality in men with Klinefelter syndrome.
Design and Setting: We obtained data about patients diagnosed with Klinefelter syndrome at almost all cytogenetics centers in Britain, as far back as records were available, and conducted a cohort study of their mortality, overall and by karyotype.
Patients: We assessed 3518 patients diagnosed since 1959, followed to mid-2003.
Outcome Measure: The outcome measure was standardized mortality ratio (SMR).
Results: A total of 461 deaths occurred. There was significantly raised mortality overall [SMR, 1.5; 95% confidence interval (CI), 1.4–1.7] and from most major causes of death including cardiovascular disease (SMR, 1.3; 95% CI, 1.1–1.5), nervous system disease (SMR, 2.8; 95% CI, 1.6–4.6), and respiratory disease (SMR, 2.3; 95% CI, 1.8–2.9). Mortality was particularly raised from diabetes (SMR, 5.8; 95% CI, 3.4–9.3), epilepsy (SMR, 7.2; 95% CI, 3.1–14.1), pulmonary embolism (SMR, 5.7; 95% CI, 2.5–11.3), peripheral vascular disease (SMR, 7.9; 95% CI, 2.9–17.2), vascular insufficiency of the intestine (SMR, 12.3; 95% CI, 4.0–28.8), renal disease (SMR, 5.0; 95% CI, 2.0–10.3), and femoral fracture (SMR, 39.4; 95% CI, 4.8–142.3). Mortality from ischemic heart disease was significantly decreased (SMR, 0.7; 95% CI, 0.5–0.9).
Conclusions: Patients diagnosed with Klinefelter syndrome have raised mortality from several specific causes. This may reflect hormonal and genetic mechanisms.
6516-6522
Swerdlow, Anthony J.
5f6c764b-1374-49d1-bcee-1bdae5f47b9d
Higgins, Craig D.
93df71b7-f76b-4b16-9a5b-359ae84377d2
Schoemaker, Minouk J.
d6949f41-d64c-4b46-aedb-d6a87c36797f
Wright, Alan F.
7efbb151-a98c-4398-b69f-92d5cac84f50
Jacobs, Patricia A.
d87ec15b-13c3-4868-96f1-b4b99030fa5b
United Kingdom Clinical Cytogenetics Group
December 2005
Swerdlow, Anthony J.
5f6c764b-1374-49d1-bcee-1bdae5f47b9d
Higgins, Craig D.
93df71b7-f76b-4b16-9a5b-359ae84377d2
Schoemaker, Minouk J.
d6949f41-d64c-4b46-aedb-d6a87c36797f
Wright, Alan F.
7efbb151-a98c-4398-b69f-92d5cac84f50
Jacobs, Patricia A.
d87ec15b-13c3-4868-96f1-b4b99030fa5b
Swerdlow, Anthony J., Higgins, Craig D., Schoemaker, Minouk J., Wright, Alan F. and Jacobs, Patricia A.
,
United Kingdom Clinical Cytogenetics Group
(2005)
Mortality in patients with Klinefelter syndrome in Britain: a cohort study.
Journal of Clinical Endocrinology & Metabolism, 90 (12), .
(doi:10.1210/jc.2005-1077).
Abstract
Context: Klinefelter syndrome is characterized by hypogonadism and infertility, consequent on the presence of extra X chromosome(s). There is limited information about long-term mortality in this syndrome because there have been no large cohort studies.
Objective: Our objective was to investigate mortality in men with Klinefelter syndrome.
Design and Setting: We obtained data about patients diagnosed with Klinefelter syndrome at almost all cytogenetics centers in Britain, as far back as records were available, and conducted a cohort study of their mortality, overall and by karyotype.
Patients: We assessed 3518 patients diagnosed since 1959, followed to mid-2003.
Outcome Measure: The outcome measure was standardized mortality ratio (SMR).
Results: A total of 461 deaths occurred. There was significantly raised mortality overall [SMR, 1.5; 95% confidence interval (CI), 1.4–1.7] and from most major causes of death including cardiovascular disease (SMR, 1.3; 95% CI, 1.1–1.5), nervous system disease (SMR, 2.8; 95% CI, 1.6–4.6), and respiratory disease (SMR, 2.3; 95% CI, 1.8–2.9). Mortality was particularly raised from diabetes (SMR, 5.8; 95% CI, 3.4–9.3), epilepsy (SMR, 7.2; 95% CI, 3.1–14.1), pulmonary embolism (SMR, 5.7; 95% CI, 2.5–11.3), peripheral vascular disease (SMR, 7.9; 95% CI, 2.9–17.2), vascular insufficiency of the intestine (SMR, 12.3; 95% CI, 4.0–28.8), renal disease (SMR, 5.0; 95% CI, 2.0–10.3), and femoral fracture (SMR, 39.4; 95% CI, 4.8–142.3). Mortality from ischemic heart disease was significantly decreased (SMR, 0.7; 95% CI, 0.5–0.9).
Conclusions: Patients diagnosed with Klinefelter syndrome have raised mortality from several specific causes. This may reflect hormonal and genetic mechanisms.
This record has no associated files available for download.
More information
Published date: December 2005
Identifiers
Local EPrints ID: 24970
URI: http://eprints.soton.ac.uk/id/eprint/24970
ISSN: 0021-972X
PURE UUID: a3c48152-759a-49c4-b091-774b8f89f22c
Catalogue record
Date deposited: 04 Apr 2006
Last modified: 15 Mar 2024 06:59
Export record
Altmetrics
Contributors
Author:
Anthony J. Swerdlow
Author:
Craig D. Higgins
Author:
Minouk J. Schoemaker
Author:
Alan F. Wright
Author:
Patricia A. Jacobs
Corporate Author: United Kingdom Clinical Cytogenetics Group
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics